ONXX Onyx Pharmaceuticals, Inc. (MM)

Onyx Pharmaceuticals to Present at Lazard Life Sciences Conference RICHMOND, Calif., Nov. 22 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Lazard Life Sciences conference on Tuesday, November 30, at 9:00 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at: http://www.wsw.com/webcast/lz/onxx It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. If you are unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through December 30. Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at http://www.onyx-pharm.com/. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alexandra Santos of Onyx Pharmaceuticals, Inc., +1-510-243-3695 Web site: http://www.onyx-pharm.com/

Copyright